These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16757349)

  • 1. Characterization of RERG: an estrogen-regulated tumor suppressor gene.
    Key MD; Andres DA; Der CJ; Repasky GA
    Methods Enzymol; 2006; 407():513-27. PubMed ID: 16757349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tools to study the function of the Ras-related, estrogen-regulated growth inhibitor in breast cancer.
    Hanker AB; Morita S; Repasky GA; Ross DT; Seitz RS; Der CJ
    Methods Enzymol; 2008; 439():53-72. PubMed ID: 18374156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.
    Luo RZ; Fang X; Marquez R; Liu SY; Mills GB; Liao WS; Yu Y; Bast RC
    Oncogene; 2003 May; 22(19):2897-909. PubMed ID: 12771940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rig is a novel Ras-related protein and potential neural tumor suppressor.
    Ellis CA; Vos MD; Howell H; Vallecorsa T; Fults DW; Clark GJ
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9876-81. PubMed ID: 12107278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer.
    Finlin BS; Gau CL; Murphy GA; Shao H; Kimel T; Seitz RS; Chiu YF; Botstein D; Brown PO; Der CJ; Tamanoi F; Andres DA; Perou CM
    J Biol Chem; 2001 Nov; 276(45):42259-67. PubMed ID: 11533059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
    Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
    Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and characterization of a novel small monomeric GTPase, RasL10B, with tumor suppressor potential.
    Zou H; Hu L; Li J; Zhan S; Cao K
    Biotechnol Lett; 2006 Dec; 28(23):1901-8. PubMed ID: 17028781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.
    Ho JY; Hsu RJ; Liu JM; Chen SC; Liao GS; Gao HW; Yu CP
    Oncotarget; 2017 Apr; 8(14):22443-22459. PubMed ID: 27705918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
    Kawakubo H; Brachtel E; Hayashida T; Yeo G; Kish J; Muzikansky A; Walden PD; Maheswaran S
    Cancer Res; 2006 Jul; 66(14):7075-82. PubMed ID: 16849553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
    Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
    Endocr Relat Cancer; 2006 Dec; 13(4):1109-20. PubMed ID: 17158757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma.
    Zhao W; Ma N; Wang S; Mo Y; Zhang Z; Huang G; Midorikawa K; Hiraku Y; Oikawa S; Murata M; Takeuchi K
    J Exp Clin Cancer Res; 2017 Jun; 36(1):88. PubMed ID: 28659184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.
    Yang C; Trent S; Ionescu-Tiba V; Lan L; Shioda T; Sgroi D; Schmidt EV
    Cancer Res; 2006 Dec; 66(24):11649-58. PubMed ID: 17178859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
    Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the RERG gene is gender-dependent in hepatocellular carcinoma and regulated by histone deacetyltransferases.
    Wang AG; Fang W; Han YH; Cho SM; Choi JY; Lee KH; Kim WH; Kim JM; Park MG; Yu DY; Kim NS; Lee DS
    J Korean Med Sci; 2006 Oct; 21(5):891-6. PubMed ID: 17043425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer.
    Lin CY; Ström A; Li Kong S; Kietz S; Thomsen JS; Tee JB; Vega VB; Miller LD; Smeds J; Bergh J; Gustafsson JA; Liu ET
    Breast Cancer Res; 2007; 9(2):R25. PubMed ID: 17428314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA.
    Liang ZD; Lippman SM; Wu TT; Lotan R; Xu XC
    Cancer Res; 2006 Jul; 66(14):7111-8. PubMed ID: 16849557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-expression of tumorigenicity after attenuation of human synaptotagmin 13 in a suppressed microcell hybrid cell line.
    Jahn JE; Coleman WB
    Int J Oncol; 2008 Feb; 32(2):441-9. PubMed ID: 18202767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
    Wakefield L; Robinson J; Long H; Ibbitt JC; Cooke S; Hurst HC; Sim E
    Genes Chromosomes Cancer; 2008 Feb; 47(2):118-26. PubMed ID: 17973251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.